Skip to content

Clinical Study on the Efficacy and Mechanism of "Foqiao" Facial Mask for Pigmentary Skin Disorders

Clinical Study on the Efficacy and Mechanism of "Foqiao" Facial Mask for Pigmentary Skin Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001491
Enrollment
Unknown
Registered
2025-07-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

Experimental group:Foqiao Facial Mask" (for topical use): Cleanse the face, then prepare the mask by mixing one sachet of herbal granules (daily dose) with 5ml warm water to form a paste. Apply the pa
Control group:The glycolic acid peeling solution was applied to the treatment area, starting at 20% concentration and gradually increasing to 50% based on patient tolerance. Initial application durati

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meeting both Chinese and Western diagnostic criteria for melasma: classified as stable phase in Western medicine diagnosis and qi stagnation with blood stasis pattern in TCM diagnosis; (2) Female patients aged between 18 and 70 years; (3) No use of Chinese or Western medications specifically for melasma treatment nor any other melasma-targeted therapies within 3 months prior to treatment; (4) Voluntary participation in this study with signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women or those taking oral contraceptives long-term; (2) Patients who have received other relevant treatments within the past three months; (3) Patients with severe cardiovascular/cerebrovascular diseases mental disorders or organic diseases of the liver kidneys hematopoietic system or nervous system; (4) Patients with facial skin lesions; (5) Patients allergic to the test drug or unable to tolerate the treatment method; (7) Outdoor workers.

Design outcomes

Primary

MeasureTime frame
MASI Score (Melasma Area and Severity Index Score);

Secondary

MeasureTime frame
VISIA Imaging System;

Countries

China

Contacts

Public ContactYonghua Su

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

suyh2001@shutcm.edu.cn+86 151 4660 6249

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026